Daiken Medical Co., Ltd.
Tokyo Stock ExchangeTotal Valuation
Daiken Medical Co., Ltd. carries a market capitalization of 12.07B, placing it among publicly traded companies globally. Its enterprise value stands at 14.33B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 12.07B |
| Enterprise Value | 14.33B |
Share Statistics
Daiken Medical Co., Ltd. currently has 28.73M shares outstanding.
| Shares Outstanding | 28.73M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Daiken Medical Co., Ltd. trades at a trailing price-to-earnings ratio of 33.32. The price-to-sales ratio is 3.05, and the price-to-book ratio stands at 1.73.
| PE Ratio | 33.32 |
| PS Ratio | 3.05 |
| PB Ratio | 1.73 |
| P/TBV Ratio | 2.07 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Daiken Medical Co., Ltd. trades at an EV/EBITDA multiple of 20.55 and an EV/FCF ratio of 9,019.89. The EV/Sales ratio of 2.91 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 20.55 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.91 |
| EV / EBITDA | 20.55 |
| EV / EBIT | 20.55 |
| EV / FCF | 9,019.89 |
Financial Position
Daiken Medical Co., Ltd. maintains a current ratio of 2.36, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 33.81, indicating elevated leverage, while an interest coverage ratio of 288.39 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.36 |
| Quick Ratio | 1.04 |
| Debt / Equity | 33.81 |
| Debt / EBITDA | 3.53 |
| Interest Coverage | 288.39 |
Financial Efficiency
Daiken Medical Co., Ltd. posts a return on equity of 5.34 and a return on invested capital of 4.65.
| Return on Equity (ROE) | 5.34 |
| Return on Assets (ROA) | 3.98 |
| Return on Invested Capital (ROIC) | 4.65 |
| Return on Capital Employed (ROCE) | 4.11 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.98 |
Taxes
Over the trailing twelve months, Daiken Medical Co., Ltd. has paid 235.38M in income taxes, reflecting an effective tax rate of 34.30.
| Income Tax | 235.38M |
| Effective Tax Rate | 34.30 |
Stock Price Statistics
Daiken Medical Co., Ltd.'s stock has declined approximately -4.7619% over the past 52 weeks. The 50-day moving average sits at 441.58, while the 200-day moving average is 452.93.
| Beta (5Y) | N/A |
| 52-Week Price Change | -4.7619% |
| 50-Day Moving Average | 441.58 |
| 200-Day Moving Average | 452.93 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Daiken Medical Co., Ltd. generated 4.93B in revenue and converted that into 450.93M in net income, yielding earnings per share of 15.70. EBITDA reached 697.33M, while operating income came in at 697.33M.
| Revenue | 4.93B |
| Gross Profit | 1.99B |
| Operating Income | 697.33M |
| Pretax Income | 686.30M |
| Net Income | 450.93M |
| EBITDA | 697.33M |
| EBIT | 697.33M |
| Earnings Per Share (EPS) | 15.70 |
Balance Sheet
Daiken Medical Co., Ltd. holds 3.16B in cash and equivalents against 2.46B in total debt, resulting in a net debt position of -693.36M. Total book value stands at 8.68B, with working capital of 4.12B providing operational flexibility.
| Cash & Cash Equivalents | 3.16B |
| Total Debt | 2.46B |
| Net Debt | -693.36M |
| Equity (Book Value) | 8.68B |
| Book Value Per Share | 302.17 |
| Working Capital | 4.12B |
Margins
Daiken Medical Co., Ltd. operates with a gross margin of 40.37, reflecting its pricing power and cost economics. The operating margin of 14.16 and net profit margin of 9.15 provide insight into operational efficiency.
| Gross Margin | 40.37 |
| Operating Margin | 14.16 |
| Pretax Margin | 13.93 |
| Profit Margin | 9.15 |
| EBITDA Margin | 14.16 |
Stock Splits
Daiken Medical Co., Ltd.'s most recent stock split took place on November 13, 2014 with a 1:2 split ratio.
| Last Split Date | 11/13/2014 |
| Split Ratio | 1:2 |
Scores
Daiken Medical Co., Ltd. posts an Altman Z-Score of 4.27, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.27 |